Dr. Elena Bortan, a board-certified neurologist and member of the American Academy of Neurology and the Movement Disorder Society, will visit St. Joseph’s Living Center to discuss various treatment ...

"For too long, the Parkinson's community has had limited treatment options for advanced disease," Dr. Robert A. Hauser, professor of neurology at the University of South Florida said in a press ...

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...

"For too long, the Parkinson's community has had limited treatment options for advanced disease. Due to the progressive nature of the disease, oral medications are eventually no longer as ...

"For too long, the Parkinson's community has had limited treatment options for advanced disease," said Dr. Robert A. Hauser, professor of neurology at the University of South Florida, in prepared ...

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.

The rising prevalence of conditions such as Alzheimer's, Parkinson's, multiple sclerosis, and stroke is fueling the demand for both diagnostic and therapeutic solutions. As medical technology advances ...

"For too long, the Parkinson's community has had limited treatment options for advanced disease," Robert Hauser, MD, MBA, of the University of South Florida in Tampa, said in an AbbVie news release.

It had an excellent phase 1b dataset with a very strong treatment effect on the primary endpoint that ... with leading ...